Cure8 research brief
Digital health tools could offer more continuous monitoring and self-management support for people with IBD, potentially helping detect flares earlier and improve quality of life. This review collects existing evidence and highlights gaps needing improvement.
Adult patients with IBD and their caregivers, clinicians managing IBD, and researchers developing or evaluating digital health interventions.
This systematic review (PRISMA-guided) summarizes studies of digital health tools (DHTs) used to support management of IBD, including Crohn’s disease and ulcerative colitis. The authors screened literature from 2006–2025 and analyzed 15 articles, focusing on types of DHTs, study quality, usability, acceptability, and target topics.
The review found DHTs are promising for continuous monitoring and self-management but need refinement and better adaptation to patient-group needs.
Examples discussed across the included studies likely cover symptom tracking, remote monitoring, and tools tied to biomarkers or data-driven decision support, though the abstract emphasizes overall themes rather than specific validated interventions.
Practical takeaway: digital tools may help bridge gaps in periodic clinic-based care by supporting symptom monitoring and timely interventions, but evidence is still evolving and tools vary in quality and fit for different patient populations.
This entry is based on the article abstract (systematic review) indexed on PubMed. The review covers literature through 2025 and synthesizes 15 studies; it reports general conclusions about promise and the need for further refinement rather than definitive clinical recommendations.
Details about specific tools, study designs, and outcomes require reading the full review or the original included studies.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
AI could help identify dietary patterns, predict which patients might benefit from specific nutrition approaches, and provide personalized nutrition support — potentially improving inflammation and gut microbiome...
AI could help make IBD assessments (endoscopy, histology, imaging, biomarkers) more objective and faster, which may improve monitoring, treatment selection, and early detection of complications for people with Crohn’s...
Digital self-management programs could help people with active IBD build skills to manage symptoms and quality of life between clinic visits. This trial tests whether such a program is feasible, acceptable, and practical...
